Compugen to Release First Quarter 2023 Results on Monday, Ma

HOLON, Israel, May 1, 2023 /PRNewswire/ -- Compugen Ltd. a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will... | May 1, 2023

Related Keywords

Israel , Tel Aviv , San Francisco , California , United States , Yvonne Naughton , Nasdaq , Corporate Communications , Compugen Ltd , Astrazeneca , Prnewswire Compugen Ltd , Compugen , Stock Exchange , Investor Relations , Compugen Ltd Stock Exchange , News , Information , Press Release , Bay , 023 , Dancer , Immunotherapy , Company , End , Pioneer , N , Computational , Target , Oday , Nnounced , Hat , The , Ompany Cgen Il0010852080 ,